Terms and Conditions

Last update: 08/19/2024

These Terms of Use (“Terms”) set forth the terms and conditions governing your use of the www.massivebio.com website and its affiliate websites (“Website”), and services provided there, Synergy-AI Clinical Trial Finder and Cancer Quiz mobile applications (“Mobile Apps”), Clinical Trial Matching, Virtual Tumor Board, Clinical Network, Drug Utilization Optimizer (“DUO“), Real World Data and other online and off-line applications (“Platforms”), including cancer patients (“you” / “your”), your oncologists, referring physicians, primary investigators and clinic staff, expert oncologists who evaluate your case history and identify options for treatment or clinical trials, which is presented by Massive Bio, (“Company”, “we”, “us” or “our”). From now on, collectively, Website, Mobile Apps, and Platforms are noted as “Solutions”.

Massive Bio is a data analytics firm that provides a medical second opinion and clinical trial matching by evaluating a cancer patient’s existing clinical information, leveraging our proprietary artificial intelligence platform, and providing consulting services to patients’ oncologists by identifying and explaining treatment options that best fit the patient’s genomic profile, treatment objectives, and resources (collectively, the “Services”). Please see our Privacy Policy for more information on Massive Bio’s processing of personal data.

The Terms form a legal contract between you and Company, governing your access to the Solutions and use of the Services. Please read the Terms carefully before using the Services. In addition, if you are using a particular service on the Solutions or accessed via the Solutions, you agree to be subject to any rules or guidelines applicable to such services. Such regulations or policies will be incorporated by reference within these Terms. By using the Services, you acknowledge that you have read, understood, and accept, without limitation or qualification, the Terms.

Do not use the Services if you do not accept the Terms. ARBITRATION NOTIFICATION: THESE TERMS OF USE PROVIDE THAT ALL DISPUTES WILL BE RESOLVED BY BINDING ARBITRATION AND NOT IN COURT OR BY JURY TRIAL. YOU ALSO AGREE TO RELINQUISH YOUR RIGHT TO PARTICIPATE AS A CLASS REPRESENTATIVE OR CLASS MEMBER ON ANY CLASS ACTION CLAIM YOU MAY HAVE AGAINST MASSIVE BIO.

1. Eligibility

The Solutions and our Services are designed to comply with the laws and regulations of the United States (the “U.S.”), European Union Countries(“EU”), Canada, and other countries where Massive Bio provides Solutions. The Solutions and Services are intended for access and use by U. S. residents, EU residents, Canada residents and other country residents Massive Bio provides Services. The Company makes no representation that the Services are appropriate for use in any other jurisdiction. If you choose to access the Solutions from other locations that Massive Bio does not Serve, you do so upon your initiative and are responsible for compliance with applicable local laws and regulations. Massive Bio can decide to alter, decide, start, stop Services for any country any time with or without any notification to any parties.
You acknowledge that you are 18 years of age or older. Those under 18 are not allowed to visit or otherwise use the Solutions on their behalf, and we do not knowingly collect information from such persons.

2. Disclaimers

The information provided on the Solutions is for informational or educational purposes only. Massive Bio is not engaged in rendering medical services via the Solutions. The information provided is not a substitute for the professional judgment of a health care professional who physically examines, diagnoses, and treats patients. You should consult a physician or other medical professional for advice regarding any medical condition or treatment. We serve a supporting role for your primary physician or oncologist.
Your reliance upon any content or information provided on the Solutions and the Services is solely at your own risk. The Solutions may not be up to date or may not accurately represent the complete breadth and details of oncology treatment options or patient assistance program options. There may be local programs or recently updated national programs not described on the Solutions. It would help if you did not construe the Company’s publication of any such content as an endorsement by the Company of the views expressed in it or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of medication or preparation made by the author of the content.
Massive Bio is a data analytics firm that evaluates existing clinical information and data. Massive Bio is not a health care provider, and no patient-provider relationship is established by your request for Services from Massive Bio. Massive Bio will not physically observe or examine you, test your blood or tissue samples, or take any anatomical images for either diagnostic or therapeutic purposes.
Massive Bio is not practicing medicine and is not licensed, registered, certified, and otherwise qualified to practice medicine or deliver medical services in any state.
Massive Bio assumes that the clinical information and data about you furnished by your health care providers are accurate and complete. Massive Bio is neither responsible nor liable to anyone for any incorrect or incomplete reporting to you or your primary oncologist due to inaccurate, incomplete, or unreadable clinical information or data that Massive Bio received from your health care providers.
Massive Bio disclaims all express and implied warranties, including implied warranties of merchantability and fitness for a particular purpose. Massive Bio does not make any representations regarding its report’s accuracy, completeness, or reliability.
Massive Bio will issue its report to you or your primary oncologist. Your primary oncologist may choose to use or not use Massive Bio’s report at their sole discretion.
After an initial review of your clinical information and data, Massive Bio may decline to process your request and return your payment if Massive Bio concludes in its sole discretion that its services would not be helpful to you or your primary oncologist.
Massive Bio grants nonexclusive, worldwide, and perpetual licenses to perform, display, and use Mobile Apps on the Device.

3. Modification of these Terms and the Solutions

You are responsible for regularly reviewing these Terms. The company has the right, but not the obligation, to correct any errors or omissions in any portion of the Solutions, the Services, and these Terms. Company reserves the right, at its sole discretion, to change, modify, add, remove or terminate any portion of the Solutions, the Services, and these Terms, in whole or in part, at any time, without prior notice. All changes to these Terms are effective immediately upon posting to the Solutions. Your continued use of the Solutions or Services following any changes to these Terms will mean you accept these changes.

4. Restrictions on Solutions Use

You may not access or use, or attempt to access or use, the Solutions or Services to take any action that could harm us or any third party, interfere with the operation of the Solutions, or use the Solutions in a manner that violates any laws. Without limiting the foregoing, you agree not to:

Impersonate any person or entity or falsely state or otherwise misrepresent your affiliation with any person or entity or the origin of any information you provide;
Use any device, software, or routine to interfere or attempt to interfere with the proper working of the Solutions, the Services, or any activity conducted on the Solutions or try to probe, scan, test the vulnerability of, or breach the security of any system or network;
Circumvent, reverse engineer, decipher, decompile, disassemble, decrypt, or otherwise alter or interfere with (or attempt, encourage, or support anyone else’s attempt to engage in such activities) any of the software comprising or in any way making up a part of the Service. The use or distribution of tools designed for compromising security (e.g., password guessing programs, cracking tools, or network probing tools) is strictly prohibited;
Engage in unauthorized use of bots, spiders, scraping, or harvesting of content or information, or use any other unauthorized automated means to compile information;
Obtain or attempt to gain unauthorized access to other computer systems, materials, information, or any services available on or through the Service;
Take any action that imposes an unreasonable or disproportionately large load on our network or infrastructure;
Upload or otherwise transmit any communication, software, or material that infringes the rights of third parties, contains a virus or is otherwise harmful to our user’s computers or systems; or
Engage in any other conduct that restricts or inhibits any person from using or enjoying the Solutions or Services, or that, in our sole discretion, exposes us or others to any form of harm or liability.

Violations of system or network security and certain other conduct may result in civil or criminal liability. We may investigate and work with law enforcement authorities to prosecute users who violate the Terms. We may suspend or terminate your access to the Solutions without notice.

5. Information Disclosure

Disclosure under Law. Company always reserves the right to disclose any information as necessary to satisfy any applicable law, regulation, legal process, or governmental request, including personally identifiable information, or to edit, refuse to allow, or remove any information or materials, in whole or in part, in Company’s sole discretion.
Providing Correct Personal Information. In using the Solutions, you may be required to enter certain information, including, without limitation, personal information (collectively, “Information”). You represent and warrant that you will provide the Company with complete, true, and correct information and update such Information on the Solutions promptly as reasonably necessary and required by the Solutions.

6. Materials

There are two types of Materials you may submit: (“Account Materials” that relate to you and your health information that are uploaded for purposes of accessing the Services, including applying for a patient, applying for reimbursement, or making a donation, and (“General Materials” such as comments or feedback you submit to the Solutions.

Account Materials. You must register on the Solutions to apply for Services by creating a user profile. When you register, you agree to provide accurate, current, and complete information about yourself as requested or directed on the Solutions and promptly update this information to maintain its accuracy. Company has the right to suspend or terminate any account or other registration and to refuse any current or future use of the Solutions if it suspects that such information is inaccurate or incomplete. You are responsible for maintaining the confidentiality of any password and username that you are given or select in connection with the Service. You are responsible for all activities that occur under your password or account.
General Materials. Suppose you submit information or materials to us (including without limitation ideas, know-how, concepts, techniques, feedback, data, questions, comments, suggestions, strategies, artwork, statistics, graphs, processes, plans, freeware, scripts, code or vulnerabilities). In that case, you grant Company an unrestricted, perpetual, irrevocable, royalty- free, worldwide, transferable, and sublicensable license to use in any way for any commercial or non-commercial purpose, including without limitation the right to reproduce, copy, display (publicly or otherwise), perform (publicly or otherwise), modify, transmit, distribute, edit, reformat, translate, and do derivative works from those materials or information. You understand that you will not be compensated or credited for any such use. You agree that you shall have no recourse against the Company or any right to license fees or royalties for any alleged or actual infringement or misappropriation of any property included in your communications.
Your Responsibility for Materials and Company’s Monitoring Rights. You will be responsible for your Materials and the consequences of transmitting those Materials. Company has no obligation to monitor you or any other user’s use of the Solutions. Company reserves the right to review and monitor your use of the Solutions, including without limitation your use of any user ID and password in accessing the Solutions and any Materials Submitted to or revised on the Solutions, and to remove any Materials that the Company believes in its sole discretion violate these Terms. Company reserves the right to restrict or terminate your access to the Solutions, including, without limitation, your access to any or all of the services provided thereunder or your ability to use any Website user ID and password, at any time without notice if we believe you have violated these Terms or are likely to violate these Terms. Your sole remedy against the Company in the event of a dispute arising out of these Terms, the Solutions, or your use thereof, is to terminate these Terms by ceasing your use of the Solutions. In the event of termination of these Terms, Company may delete and store, at its discretion, Materials, and data associated with your use of the Solutions. Company may also change, suspend, or discontinue any aspect of the publicly available portion of the Solutions, including the availability of any Website feature, database, or content. About the password-protected part of the Solutions, Company will provide you with thirty (30) days’ notice before materially changing, suspending, or discontinuing any aspect of this portion of the Solutions.

7. Commitment to Diversity Inclusion (D&I)

The Company unequivocally pledges to foster a work environment characterized by diversity and inclusion. This commitment is integrated into the Company’s operations and is reflected in a variety of initiatives and practices. By adhering to these principles and incorporating D&I objectives into our organizational structure, we strive to create an environment conducive to the prosperity of all employees. This, in turn, fuels innovation and enhances our ability to effectively serve our clients, patients, and any individual or organization working with Massive Bio.

Leadership Responsibility. The Company’s leadership assumes the responsibility to advocate, endorse, and sustain D&I at all organizational echelons. Leaders are obligated to embody our inclusive culture, actively engage in diversity initiatives, and expressly convey the significance of D&I to all personnel.
Policies and Guidelines. The Company has instituted definitive policies and guidelines to ensure the consistent application of D&I principles in its regular operations. These directives encompass areas such as recruitment, promotions, training, and harassment prevention, with an overarching aim to provide equal opportunities for all.
Recruitment and Hiring Practices. The Company is resolved to construct a diverse workforce by actively sourcing candidates from a broad range of backgrounds, skills, and experiences. This includes collaborations with diverse job platforms, participation in career fairs aimed at underrepresented groups, and the adoption of blind recruitment techniques to mitigate unconscious bias.
Employee Resource Groups (ERGs). The Company’s ERGs offer support, mentorship, and networking avenues for employees from diverse backgrounds. These groups are instrumental in cultivating an inclusive workplace ethos and promoting diverse viewpoints in decision-making processes.
Training and Development. The Company is committed to investing in training and development programs designed to enlighten employees about unconscious bias, cultural sensitivity, and inclusive communication. This initiative is aimed at enabling the workforce to foster an environment where all feel valued, respected, and can contribute to their full potential.
Accountability. The Company upholds the principle of accountability in relation to its D&I objectives. This involves regular scrutiny of our policies, practices, and initiatives, and the implementation of improvements based on the findings of these reviews.
Community Engagement. The Company recognizes its responsibility to contribute to the communities in which it operates. We partner with local organizations that advocate for diversity, inclusion, and equal opportunities, and encourage our employees to engage in these initiatives.

8. Your Account

Security of Account and Password. Suppose you establish an account and receive or establish a password for such an account. In that case, you are responsible for maintaining the confidentiality of your account and password and for restricting access to your computer. You accept full responsibility and liability for all activities under your account or password. Company reserves the right to refuse service, terminate accounts or remove the content at its sole discretion.
Notification of Unauthorized Use/Ceasing Access. You shall notify Company immediately of any unauthorized use or threat of unauthorized use of your account or the Solutions or any other breach or potential breach of security known to you concerning your account or the Solutions, including without limitation any loss or compromise of any password, and will cooperate with Company in every reasonable way to help Company prevent the further unauthorized use, threat of unauthorized use, disclosure or threat of disclosure regarding the Solutions, your account, and your password. You agree that immediately upon termination of your right to use the Solutions or any password-protected portion of the Solutions, or upon any earlier demand by Company at any time, you will cease all access and use of the Solutions or such password-protected portion of the Solutions and will not attempt to access and use same.

9. Regulations: USA

Regulatory Compliance and Certifications. Massive Bio operates in compliance with relevant regulations and guidelines governing healthcare services in the United States, including the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and guidelines established by the Food and Drug Administration (FDA).
Federalwide Assurance (FWA), FDA Compliance, and Data Protection. We adhere to a Federalwide Assurance (FWA) approach, ensuring compliance with regulations set forth by the FDA, as well as guidelines outlined by the European Data Protection Board (EDPB). Our commitment to regulatory compliance extends to the highest standards, including those mandated by the FDA.
Security and Compliance Certification. Massive Bio maintains SOC 2 certification, demonstrating our commitment to data security and regulatory compliance.
Privacy Policy. Our comprehensive privacy policy is available for review on our website at: Privacy Policy
Additional Certifications. In addition to our adherence to HIPAA and FDA guidelines, we have obtained certifications to further ensure quality, patient protection, and privacy assurance: (1) Office for Human Research Protections (OHRP) Approval. Massive Bio’s Federalwide Assurance (FWA) has been approved by the Office for Human Research Protections (OHRP). This approval signifies our commitment to compliance beyond the requirements of HIPAA, particularly in the context of clinical research. (2) Comprehensive Compliance Documentation. Massive Bio has submitted all necessary documentation to the OHRP, indicating our commitment to adhere to the requirements outlined in 45 CFR part 46 when conducting non- exempt human subjects’ research supported by the Department of Health and Human Services (HHS) or other research covered by our assurance. (3) Verification of Federalwide Assurance. Our Federalwide Assurance (FWA) has been officially recognized and approved by the OHRP. Verification of our assurance status can be found at OHRP Assurance Database using the identification number FWA00030601.

10. Regulations: Canada

Compliance with Canadian Data Protection Laws. Massive Bio is committed to upholding Canadian data protection laws, including applicable provincial and and territorial law, and the Personal Information Protection and Electronic Documents Act (PIPEDA) to the extent it is legally applicable to the kind of information we may collect, use and/or disclose. In addition to our SOC 2 certification and strict adherence to HIPAA and GDPR regulations, we ensure compliance with Canadian data privacy laws in all aspects of our operations.
Dedicated Canadian Data Protection Officer (DPO). To oversee our compliance efforts in Canada, we have appointed a dedicated Data Protection Officer (DPO). This role is integral to ensuring that our data handling practices align with Canadian laws and standards. Our DPO, Cagatay Culcuoglu, who also serves as our Chief Privacy Officer and Co-Founder, is responsible for overseeing our compliance with Canadian data privacy regulations. Additionally, our Head of Product is physically located in Canada, further reinforcing our commitment to compliance with Canadian data protection laws.

11. Regulations: India

Compliance with Indian Data Protection Laws. Massive Bio is committed to upholding Indian data protection laws, including the Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011, under the Information Technology Act, 2000. We ensure compliance with these regulations in all aspects of our operations, including the digital collection of sensitive personal data or information (SPDI) with explicit consent from the patient.
Dedicated Indian Data Protection Officer (DPO). To oversee our compliance efforts in India, we have appointed a dedicated Data Protection Officer (DPO). This role is integral to ensuring that our data handling practices align with Indian laws and standards. Our DPO is responsible for overseeing our compliance with Indian data privacy regulations, ensuring that your sensitive personal data is protected and handled in accordance with the law.

12. Regulations: Australia

Compliance with Australian Data Protection Laws. Massive Bio is committed to upholding Australian data protection laws, including the Privacy Act 1988 and the Australian Privacy Principles (APPs). We ensure compliance with these regulations in all aspects of our operations, including the digital collection of sensitive personal data or information (SPDI) with explicit consent from the patient.
Dedicated Australian Data Protection Officer (DPO). To oversee our compliance efforts in Australia, we have appointed a dedicated Data Protection Officer (DPO). This role is integral to ensuring that our data handling practices align with Australian laws and standards. Our DPO is responsible for overseeing our compliance with Australian data privacy regulations, ensuring that your sensitive personal data is protected and handled in accordance with the law.

13. Regulations: EU and Other Countries

European Medicines Agency (EMA) Registration for Clinical Trial Regulation (CTR) Purposes. Massive Bio. is registered with the European Medicines Agency (EMA) for Clinical Trial Regulation (CTR) purposes. Our registration details are as follows:
Organisation ID: ORG-100044618
Organisation Name: Massive Bio. Location ID: LOC-100073754
Location Status: ACTIVE
Date Modified: 2022-10-03
Regulatory Compliance in Europe, Israel, Brazil, and Other Countries. Massive Bio adheres to a comprehensive set of regulations in various countries to ensure compliance with legal requirements. The regulations we follow include:

European Union (EU) and United Kingdom (UK). General Data Protection Regulation (GDPR) and Clinical Trials Regulation (CTR – Regulation (EU) No 536/2014).
Germany. German Unfair Competition Act (Gesetz gegen den unlauteren Wettbewerb – “UWG”) and the German Drug Advertising Act (Heilmittelwerbegesetz – “HWG”).
France. Article L.1121-1 of the French Public Health Code (“FPHC”) and EU Good Clinical Practices (GCP) integrated into French law.
Greece. Ministerial Decision 59676/2016.
Italy. Regulations governed by the Ministry of Health, the Superior Institute of Health (“Istituto Superiore di Sanità”), and the Italian Drug Agency (“Agenzia Italiana del Farmaco”).
Poland. Compliance with the Polish clinical trials registration authority.
Romania. Compliance with Order of the Minister of Health no. 904/2006 and regulations of the National Agency for Medicines and Medical Devices of Romania (“ANMDM”).
Spain. Spanish Royal Decree 1090/2015.
Other Countries (Brazil, Colombia, Israel, Turkiye). (i) Brazil. Lei Geral de Proteção de Dados (LGPD). Clinical research activities follow the guidelines outlined by the Agência Nacional de Vigilância Sanitária (ANVISA), ensuring alignment with national laws, while also upholding international standards of Good Clinical Practices (GCP). (ii) Colombia. Compliance with relevant regulations, including those set by the Ministry of Health (MoH) and regulatory authorities such as Invima. (iii) Israel. Protection of Privacy Law (1981) and the Patient’s Rights Law (1996). Clinical research practices adhere to regulatory standards set forth by the Ministry of Health, ensuring compliance with national legislation and international Good Clinical Practice (GCP) guidelines. (iv) Turkiye. Law on the Protection of Personal Data (Kişisel Verilerin Korunması Kanunu) and the Law on the Rights of Patients (Hasta Hakları Kanunu). Clinical research practices adhere to regulations established by the Ministry of Health (Sağlık Bakanlığı), ensuring compliance with national legislation and international Good Clinical Practice (GCP) guidelines.
Additional Compliance Measures. (i) European Data Protection Board (EDPB) compliant approach. (ii)Privacy Shield Certification. (iii) EU-U.S. DPF.
Good Clinical Practice (GCP) Certification: All key team members of Massive Bio are trained and certified in Good Clinical Practice (GCP) as per the International Council for Harmonisation (ICH) E6 GCP guidelines, covering essential topics for clinical trials with drugs and biologics. This certification is maintained despite Massive Bio not conducting clinical trials, as all activities are conducted prior to informed consent.

12. User Representations and Warranties

By using or accessing the Solutions or Submitting your Materials, you (1) represent and warrant that you own or otherwise control all of the rights to your Materials necessary to grant the licenses granted in these Terms, including, without limitation, all the rights necessary for you to Submit the Materials, and have all right, power and authority to enter into these Terms and to fully perform hereunder, (2) represent and warrant that your use of the Solutions, Website content and/or Materials does not and will not violate or infringe any third party right, including but not limited to any third party intellectual property right, right of publicity or privacy, right of trade secret or confidentiality, or contractual right, or violate these Terms, or any other agreement to which you are bound or any law, rule, regulation, order or judgment to which you are subject, (3) represent and warrant that you will comply with all applicable laws, contracts and/or agreements, at your sole expense and liability, in connection with your use of or access to the Solutions, (4) represent and warrant that you will only Submit and use Materials that may be used in accordance with the licenses you have granted herein and (5) agree that Company shall not be liable to you or any third party for accepting or not accepting your Materials or for deleting or not deleting your Materials, in whole or in part.
DISCLAIMER OF REPRESENTATIONS AND WARRANTIES. YOU AGREE THAT YOUR USE OF the Solutions IS AT YOUR OWN RISK. EFFORTS BY COMPANY TO MODIFY the Solutions SHALL NOT BE DEEMED A WAIVER OF THESE LIMITATIONS. the Solutions, INCLUDING ALL CONTENT, INFORMATION, OR SERVICES PROVIDED THROUGH, OR IN CONJUNCTION WITH, the Solutions, IS PROVIDED “AS IS,” AS A CONVENIENCE TO ALL USERS WITHOUT REPRESENTATION OR WARRANTY OF ANY KIND TO YOU OR ANY THIRD PARTY, INCLUDING, WITHOUT LIMITATION, ANY EXPRESS OR IMPLIED WARRANTIES (1) OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, (2) OF INFORMATIONAL CONTENT OR ACCURACY, (3) OF NON-INFRINGEMENT, (4) OF QUIET ENJOYMENT, (5) OF TITLE, (6) THAT the Solutions WILL OPERATE IN AN ERROR-FREE, TIMELY, SECURE, OR UNINTERRUPTED MANNER, IS CURRENT AND UP TO DATE AND ACCURATELY DESCRIBES COMPANY’S PRODUCTS AND SERVICES, OR IS FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS, (7) THAT ANY DEFECTS OR ERRORS IN the Solutions WILL BE CORRECTED, OR (8) THAT the Solutions IS COMPATIBLE WITH ANY PARTICULAR HARDWARE OR SOFTWARE PLATFORM
DISCLAIMER OF LIABILITY. IN NO EVENT SHALL COMPANY AND ITS OFFICERS, DIRECTORS, AGENTS, EMPLOYEES, REPRESENTATIVES, INTERNAL OPERATING UNITS, AFFILIATES, SUBSIDIARIES, SUBLICENSEES, SUCCESSORS AND ASSIGNS, INDEPENDENT CONTRACTORS, AND RELATED PARTIES (COLLECTIVELY, WITH COMPANY, THE “COMPANY ENTITIES”) BE LIABLE TO YOU OR ANY THIRD PARTY FOR ANY LOSS OF PROFITS, LOSS OF USE, LOSS OF DATA, INTERRUPTION OF BUSINESS, OR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE USE OF the Solutions OR WITH THE DELAY OR INABILITY TO USE SAME, OR FOR ANY BREACH OF SECURITY ASSOCIATED WITH THE TRANSMISSION OF SENSITIVE INFORMATION THROUGH the Solutions, OR FOR ANY INFORMATION, PRODUCTS, AND SERVICES OBTAINED THROUGH OR VIEWED ON the Solutions, OR OTHERWISE ARISING OUT OF THE USE OF SAME, WHETHER BASED ON CONTRACT, TORT, STRICT LIABILITY, REGULATION, COMMON LAW PRECEDENT OR OTHERWISE, EVEN IF COMPANY HAS BEEN ADVISED OF THE POSSIBILITY OF DAMAGES AND EVEN IF SUCH DAMAGES RESULT FROM COMPANY’S NEGLIGENCE OR GROSS NEGLIGENCE. BECAUSE SOME STATES/JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU. IN SUCH STATES, THE LIABILITY OF COMPANY ENTITIES SHALL BE LIMITED TO THE FULLEST EXTENT PERMITTED BY LAW. ADDITIONAL DISCLAIMERS APPEAR WITHIN THE BODY OF the Solutions AND ARE INCORPORATED HEREIN BY REFERENCE. TO THE EXTENT ANY SUCH DISCLAIMERS PLACE GREATER RESTRICTIONS ON YOUR USE OF the Solutions OR THE MATERIAL CONTAINED THEREIN, SUCH GREATER RESTRICTIONS SHALL APPLY. THIS INDEMNIFICATION SHALL APPLY TO THIRD-PARTY CLAIMS AS WELL AS CLAIMS BETWEEN THE PARTIES.

13. Refunds

If the person receiving Massive Bio’s services makes the payment but passes away before Massive Bio receives medical records, the client’s family member is entitled to a full refund. If needed, a faxed or scanned soft copy of the death certificate and proof of document relating to the client will be sent to Massive Bio. After 30 days of Massive Bio’s initial request for documentation, the patient or family is no longer entitled to a refund.
Once medical records are collected by Massive Bio, no refunds will be issued to the patient. If medical records are not obtained within thirty consecutive days after the payment was received by Massive Bio, the client may request a full refund.
Once the analysis report is delivered to the requestor, they are no longer entitled to a refund. Should the patient succumb to their illness pre- or post-delivery of the analysis, no refunds will be given.
No other refund requests will be accepted if the patient does not fall under one of the categories above.

14. Indemnification

You will indemnify, defend (or settle), and hold harmless Company Entities from all claims, actions, proceedings, losses, settlements, judgments, liabilities, suits, damages, disputes, or demands, including without limitation any proceeding, investigation, or claim by a self- regulatory organization, state or federal securities agency or commission, and including reasonable attorney’s fees and all other costs, fees, and expenses (collectively, “Claims”) against any of Company Entities to the fullest extent permitted by law arising out of or in connection with (1) your conduct, provision of content or use of the Solutions, or such actions by any third party through you, (2) your violation of the rights of another person or party, (3) any Materials provided or made available by you, and (4) any breach or violation by you of your obligations under these Terms, including without limitation any breach of your representations and warranties herein. You will not settle any indemnified claim without the Company’s prior written consent; such consent is not to be unreasonably withheld. In connection with any Claims that may give rise to your indemnification obligations as set forth above, Company Entities shall have the exclusive right, at their option, to defend, compromise and settle the suit, action, or proceeding. You shall be bound by determining any claim, action, or proceeding so defended or any compromise or settlement so effected. The remedies provided in this Section are not exclusive and do not limit any other remedies available to Company Entities under this Section.

15. Confidentiality

You acknowledge that you may use and acquire Company Confidential Information by using portions of the Solutions. As used herein, “Confidential Information” means all confidential and proprietary information and trade secrets of Company, whether or not memorialized, and in any form or media, regarding Company or Company’s business, including without limitation those relating to Company’s intellectual property, technology, research and development, systems, software, business plans, business operations, strategies, financial information, technical information, customers, customer lists, suppliers, operating policies and procedures, and any third-party information that Company is required to keep confidential where such information is not generally accessible without a password. “Confidential Information” includes any account passwords. You shall not at any time, directly or indirectly, for any purpose, use, copy or disclose to any other person or entity any Confidential Information or permit others to do so other than for the purposes expressly allowed hereunder. Company may seek and obtain injunctive relief against the release or threatened release of Confidential Information, in addition to any other available legal remedies. You shall notify Company immediately if you learn of any unauthorized possession or use of the Confidential Information and will promptly furnish all details of such possession or use to Company.

16. Copyright and Other Intellectual Property

Website Ownership. The Solutions and all content, organization, graphics, design, compilation, translation, and other matters related to the Solutions (collectively, “Content”) are protected under applicable copyrights, trademarks, and other proprietary (including but not limited to intellectual property) rights under international conventions and the U.S. and other laws. The Solutions and all Content is the property of the Company and third-party licensors. All rights, titles, and interests in and to the Solutions and Content will remain with Company or third-party licensors. Other product and company names mentioned herein may be the trademarks of their respective owners. You do not acquire ownership rights to the Solutions or any Content other than any rights in the Materials you may have. You will abide by any additional copyright notices, information, or restrictions contained in any Content. You will not modify, adapt, translate, reverse engineer, decompile, or disassemble the Solutions or any Website content. You may only use the Solutions and the Content as expressly permitted herein, and any other use is prohibited. Any copying, republication, or redistribution of the Solutions or Website content, including by caching, framing, or similar means, is expressly prohibited without the prior written consent of the Company and the respective intellectual property rights holder identified in the subject content, which consent to be granted or withheld at the sole discretion of the rights holder.
Copyright Infringement Claims. Company respects the intellectual property rights of others and expects our users to do the same. If you believe that your work has been copied in a way that constitutes copyright infringement, please provide Company’s Designated Copyright Agent, identified below, with all information required by the Online Copyright Infringement Liability Limitation Act of the Digital Millennium Copyright Act (“DMCA”), 17 U.S.C. § 512, summarized as follows: (1) a physical or electronic signature of a person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed; (2) identification of the copyright work claimed to have been infringed, or, if multiple copyrighted works at a single online Website are covered by a single notification, a representative list of such works at that Website; (3) identification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information reasonably sufficient to permit us to locate the material; (4) information reasonably sufficient to permit us to contact the complaining party; (5) a statement that the complaining party has a good-faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law; (6) a statement that the information in the notification is accurate, and under penalty of perjury, that the complaining party is authorized to act on behalf of the owner of an exclusive right that is allegedly infringed; and (7) any other materials or information as may be required under the DMCA as amended from time to time or by the U.S. Copyright Office.
Copyright Agent. Under the DMCA, written notification of claimed copyright infringement must be submitted to the Company Designated Copyright Agent using the following contact information: Massive Bio Designated Copyright Agent: Email: [email protected]

ALL INQUIRIES TO THE COPYRIGHT AGENT NOT RELATED TO A COPYRIGHT INFRINGEMENT CLAIM WILL RECEIVE NO RESPONSE.

17. Dispute Resolution (Arbitration Clause)

Binding Arbitration. You and Company each agree to submit to binding arbitration in the event of a dispute, controversy, or claim (each, a “Dispute”) arising out of or in connection with these Terms or the breach, termination, enforcement, interpretation, or validity thereof (including the determination of the scope or applicability of these Terms to arbitrate), your or Company’s rights and obligations under these Terms, the Solutions, the use of the Solutions, and the information, services, and products that may be provided by or through or in connection with the Solutions. The arbitration will be held in New York City, New York, before one arbitrator individually and not as a class action. You expressly waive any right you may have to arbitrate a dispute as a class action. You also expressly waive your right to a jury trial. The arbitration will be administered by JAMS (http://www.jamsadr.com). You may obtain a copy of JAMS rules by contacting the organization. You and Company shall agree on one arbitrator to conduct the arbitration. If the parties cannot agree on an arbitrator, the arbitrator will be selected by the JAMS rules. Each party shall be responsible for its attorney, expert, and other fees unless the arbitrator awards such fees to the prevailing party. Notwithstanding anything to the contrary in this Section, to the extent you have in any manner violated or threatened to violate Company’s intellectual property rights, Company may seek (and you will not contest) injunctive or other appropriate relief in any state or federal court in New York City, New York, and you consent to exclusive jurisdiction and venue in such courts.
Arbitration Final. The arbitrator’s award is final and binding on all parties. The Federal Arbitration Act governs all arbitration under this clause and not any state law concerning arbitration. Any court having jurisdiction may enter judgment on the arbitrator’s award. If any part of this clause, other than waivers of class action rights, is deemed or found to be unenforceable for any reason, the remainder shall remain enforceable. Notwithstanding anything to the contrary contained herein, if the waiver of class action rights contained herein is not enforceable as to any person or persons, such non-enforceability shall apply to such person or persons only, and all other persons shall continue to be governed by the Arbitration Clause.
Giving Up Right of Class Action. These Terms provide that all Disputes will be resolved by binding arbitration and not in court or jury trial. IF A DISPUTE IS ARBITRATED, YOU GIVE UP YOUR RIGHT TO PARTICIPATE AS A CLASS REPRESENTATIVE OR CLASS MEMBER ON ANY CLASS CLAIM YOU MAY HAVE AGAINST COMPANY ENTITIES, INCLUDING ANY RIGHT TO CLASS ARBITRATION OR ANY CONSOLIDATION OF INDIVIDUAL ARBITRATIONS. WITHOUT LIMITATION, THIS INCLUDES GIVING UP YOUR RIGHTS TO BRING OR PARTICIPATE IN A CLASS ACTION AS OUTLINED IN ANY STATE STATUTE.
Choice of Law; Jurisdiction and Venue; Waiver of Jury Trial. To the maximum extent permitted by law, these Terms are governed by the laws of the United States of America and the State of Delaware, excluding any law or conflicts of law principle that would apply to the law of another jurisdiction. To the extent the Arbitration Clause does not govern a Dispute, you at this moment consent to the exclusive jurisdiction and venue of courts in New York City, New York, in all disputes arising out of or relating to the use of the Solutions or under these Terms; provided, however, that in the event Company issued or joined by a third party in any other court or in any other forum in respect of any matter which may give rise to a claim by Company hereunder, you consent to the jurisdiction of such court or forum over any claim which may be asserted by Company therein. You irrevocably consent to the exercise of personal jurisdiction by such courts in any such action. In addition, and notwithstanding the foregoing, you irrevocably waive any objection that you may now or hereafter have to the laying of the venue of any such suit, action, or proceeding to the fullest extent permitted by law brought in any such court. Any claim that any such suit, action, or proceeding brought in any such court has been brought in an inconvenient forum. Final judgment in any such suit, action, or proceeding brought in any such court shall be conclusive and binding upon you. It may be enforced in any court in which you are subject to a jurisdiction by a suit upon such judgment. Use of the Solutions is unauthorized in any jurisdiction that does not give effect to all provisions of these Terms, including without limitation this paragraph. To the extent the Arbitration Clause does not govern a claim, Company and you each at this moment waive the right to a trial by jury in any court and any suit, action, or proceeding, whether in tort, contract, or otherwise, in which any such party is a party, as to any claim arising out of or in connection with these Terms, your or Company’s rights and obligations under these Terms, the Solutions, use of the Solutions, and the services and products that may be provided by or through or in connection with the Solutions.

18. Miscellaneous

Viewing, Accessing, and Use Outside the United States. If and when any products or services referenced on the Solutions become available, they will become available in the United States and may not become available elsewhere. Company makes no claims that the Solutions or any products or services referenced therein may be lawfully viewed, accessed, or used outside the United States. Access or use of the Solutions or any products or services referenced therein may not be legal by certain persons or countries. If you access or use the Solutions from outside of the United States, you do so at your own risk, and you are responsible for compliance with the laws of your jurisdiction.
No Joint Venture. You agree that no joint venture, partnership, employment, or agency relationship exists between you and Company due to these Terms or your use of the Solutions.
Headings. Section headings and other captions in these Terms are used solely for the convenience of the parties, have no legal or contractual significance, and shall not be used in interpreting, construing, or enforcing any of the provisions of these Terms.
Survival. The provisions of the following sections shall survive any termination or expiration of these Sections: Disclosure Under Law, Materials, User Representations and Warranties, Disclaimers, Indemnification, Confidentiality, Copyright and Other Intellectual Property, Dispute Resolution (Arbitration Clause), Choice of Law; Jurisdiction and Venue; Waiver of Jury Trial, and Miscellaneous.
No Waiver. The failure of the Company to enforce any provision of these Terms will not be construed as a waiver or limitation of the Company’s right to subsequently enforce and compel strict compliance with that provision or any other provision of these Terms.
Assignment. You may make no assignment, delegation, or other conveyance of these Terms (by operation of law or otherwise) without the prior written consent of the Company to be given in its sole discretion. Company may assign its rights and obligations hereunder to any other party.
Statute of Limitations. Any cause of action you may have concerned your use of the Solutions must be commenced within one year after the claim or cause of action arises; any such claim will be forever barred, without regard to any contrary legislation.
Agreement Binding. If any provision of these Terms is deemed unenforceable, said provision will reflect the party’s original intent by applicable law. The remainder of these Terms will continue in full force and effect.
Notices. Notices to Company under these Terms shall be sufficient only if in writing and transmitted via personal delivery, delivered by a major commercial rapid delivery courier service, or mailed, postage or charges prepaid, by certified or registered mail, return receipt requested, to Company, with such notices being effective as of the date of actual, confirmed receipt by Company. Notices to you are deemed effective if sent to the email, SMS, fax, chat, mail address, WhatsApp or other contact information provided by you and are considered effective upon the earlier of being confirmed received or one day after having been sent.
Entire Agreement; Language of Agreement. These Terms contain the entire agreement between you and Company with respect to the Solutions. It supersedes all prior or contemporaneous communications and proposals, whether electronic, oral, or written, between the user and Company with respect to the Solutions. Any rights not expressly granted herein are reserved. A printed version of these Terms and any notice given in electronic form shall be admissible in judicial or administrative proceedings based upon or relating to these Terms to the same extent and subject to the same conditions as other business documents and records originally generated and maintained in printed form. It is the express wish of the parties that these Terms and all related documents be drawn up in English.

Inquiries regarding these Terms should be directed to [email protected] or you may also call 1-844-627-7246 to get help at any time. Contact information of the Data Protection Officer: Cagatay M. Culcuoglu, [email protected]. Physical Address: 90 West St. New York City, 10006, USA